Long-term use of intrathecal baclofen reduces neuropathic pain and its interference with general activity in spinal cord injury individuals
Authors:
- 19 May 2024
- journal article
- research article
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 124 (5) , 1631-1640
Abstract
Introduction Long-term analgesic effect of intrathecal baclofen was reported in individuals with spinal cord injury. We conducted a prospective study to evaluate the effect of intrathecal baclofen on subtypes of neuropathic pain and its interference with general activity. Materials and methods Nine spinal cord injury individuals who presented with severe spasticity and moderate to severe neuropathic pain received intrathecal baclofen via an implanted pump. We applied the ASIA Impairment Scale to assess spinal cord injury severity. Neuropathic pain was evaluated by numerical rating scale, Neuropathic Pain Symptom Inventory, and Brief Pain Inventory. Evaluations were performed at baseline and after at least 6 months of continuous intrathecal baclofen treatment. Results Intrathecal baclofen led to significant pain reduction as measured by numerical rating scale, Neuropathic Pain Symptom Inventory, and Brief Pain Inventory (p < 0.05). Improvements were significant for paroxysmal pain and dysesthesia and for pain interference with general activity, as assessed by the Brief Pain Inventory (p < 0.05). There was a significant relationship between the time since spinal cord injury and changes in paroxysmal pain as well as in the total Neuropathic Pain Symptom Inventory score (p < 0.05). The baclofen dose correlated also to the percentage changes in neuropathic pain improvement and sleep (p < 0.003). Conclusions The present results provide evidence that intrathecal baclofen effectively reduces neuropathic pain, particularly paroxysmal pain and dysesthesia, and improves pain interference and overall well-being in individuals with spinal cord injury. Clinicians should be aware of this less well-known beneficial effect of intrathecal baclofen and should consider such a treatment option for better control of neuropathic pain in individuals with spinal cord injury.Keywords
This publication has 23 references indexed in Scilit:
- Neuropathic painNeurology, 2008
- Baclofen‐enhanced spinal cord stimulation and intrathecal baclofen alone for neuropathic pain: Long‐term outcome of a pilot studyEuropean journal of pain, 2008
- Molecular Approaches for Neuropathic Pain TreatmentCurrent Medicinal Chemistry, 2007
- GABAB receptor: a site of therapeutic benefitCurrent Opinion in Pharmacology, 2006
- Development and validation of the Neuropathic Pain Symptom InventoryPain, 2004
- Types and effectiveness of treatments used by people with chronic pain associated with spinal cord injuries: influence of pain and psychosocial characteristicsSpinal Cord, 2003
- GABA and GABA Receptors in the Central Nervous System and Other Organs2002
- Intrathecal Baclofen Is Analgesic in Patients with Chronic PainAnesthesiology, 2000
- Quality of life and traumatic spinal cord injuryArchives of Physical Medicine and Rehabilitation, 1998
- Pain assessment: global use of the Brief Pain Inventory.1994